Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea
· Delayed Price · Currency is KRW
11,470
+70 (0.61%)
At close: Apr 28, 2026
Bio Solution Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 295,975 | 191,204 | 172,508 | 234,764 | 341,961 |
| Market Cap Growth | 48.37% | 10.84% | -26.52% | -31.35% | - |
| Enterprise Value | 314,792 | 210,628 | 137,327 | 198,721 | - |
| Last Close Price | 11470.00 | 7910.00 | 7166.67 | 9816.67 | 14400.00 |
| PE Ratio | 1082.73 | 699.46 | - | - | - |
| PS Ratio | 19.47 | 12.58 | 13.39 | 30.32 | 38.50 |
| PB Ratio | 9.25 | 5.97 | 5.52 | 5.03 | 7.11 |
| P/TBV Ratio | 9.50 | 6.14 | 5.65 | 5.12 | 7.24 |
| EV/Sales Ratio | 20.71 | 13.86 | 10.66 | 25.66 | - |
| Debt / Equity Ratio | 0.97 | 0.97 | 1.01 | 0.03 | 0.02 |
| Net Debt / Equity Ratio | 0.59 | 0.59 | 0.55 | -0.74 | -0.83 |
| Net Debt / EBITDA Ratio | -8.70 | -8.70 | -5.42 | 22.74 | 119.93 |
| Net Debt / FCF Ratio | -12.57 | -12.57 | -6.43 | 11.30 | 8.30 |
| Asset Turnover | 0.22 | 0.22 | - | 0.15 | - |
| Inventory Turnover | 4.10 | 4.10 | - | 3.77 | - |
| Quick Ratio | 0.53 | 0.53 | 0.57 | 19.30 | 15.67 |
| Current Ratio | 0.57 | 0.57 | 0.63 | 20.14 | 15.93 |
| Return on Equity (ROE) | 0.86% | 0.86% | - | -3.80% | - |
| Return on Assets (ROA) | -3.99% | -3.99% | - | -4.10% | - |
| Return on Capital Employed (ROCE) | -12.70% | -12.70% | -14.90% | -7.00% | -3.80% |
| Earnings Yield | 0.09% | 0.14% | -6.92% | -0.77% | -0.20% |
| FCF Yield | -0.51% | -0.78% | -1.55% | -1.31% | -1.40% |
| Buyback Yield / Dilution | -3.91% | -3.33% | -0.66% | -1.29% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.